Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inari Agriculture is a biotechnology company dedicated to redesigning seeds for a more sustainable global food system. Using its proprietary SEEDesign™ platform, the company integrates artificial intelligence and multiplex CRISPR gene-editing technology to develop high-performing crop varieties. Their primary focus is on increasing yields while significantly reducing the land, water, and fertilizer required for major crops like corn, soybeans, and wheat. By unlocking the full potential of a seed's natural genetic diversity, Inari aims to address the dual challenges of food security and climate change. The company operates with a partnership-heavy model to bring its nature-positive innovations to farmers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inari Agriculture.